BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang X, Zhou J, Gu Z, Zhang H, Gong Q, Luo K. Advances in nanomedicines for diagnosis of central nervous system disorders. Biomaterials 2021;269:120492. [PMID: 33153757 DOI: 10.1016/j.biomaterials.2020.120492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Luiz MT, Dutra JAP, Tofani LB, de Araújo JTC, Di Filippo LD, Marchetti JM, Chorilli M. Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. Pharmaceutics 2022;14:821. [DOI: 10.3390/pharmaceutics14040821] [Reference Citation Analysis]
2 Fan Z, Ren T, Wang Y, Jin H, Shi D, Tan X, Ge D, Hou Z, Jin X, Yang L. Aβ-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer's disease via enhancing microglial Aβ clearance. Biomaterials 2022;283:121452. [DOI: 10.1016/j.biomaterials.2022.121452] [Reference Citation Analysis]
3 Silva OA, Pellá MG, Popat KC, Kipper MJ, Rubira AF, Martins AF, Follmann HD, Silva R. Rod-shaped keratin nanoparticles extracted from human hair by acid hydrolysis as photothermally triggered berberine delivery system. Advanced Powder Technology 2022;33:103353. [DOI: 10.1016/j.apt.2021.11.005] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Hanif S, Muhammad P, Niu Z, Ismail M, Morsch M, Zhang X, Li M, Shi B. Nanotechnology‐Based Strategies for Early Diagnosis of Central Nervous System Disorders. Adv NanoBio Res 2021;1:2100008. [DOI: 10.1002/anbr.202100008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Huang Z, Qian K, Chen J, Qi Y, E Y, Liang J, Zhao L. A biomimetic zeolite-based nanoenzyme contributes to neuroprotection in the neurovascular unit after ischaemic stroke via efficient removal of zinc and ROS. Acta Biomater 2022;144:142-56. [PMID: 35296444 DOI: 10.1016/j.actbio.2022.03.018] [Reference Citation Analysis]
6 Marin E, Tapeinos C, Sarasua JR, Larrañaga A. Exploiting the layer-by-layer nanoarchitectonics for the fabrication of polymer capsules: A toolbox to provide multifunctional properties to target complex pathologies. Adv Colloid Interface Sci 2022;304:102680. [PMID: 35468354 DOI: 10.1016/j.cis.2022.102680] [Reference Citation Analysis]
7 Ling D. Dynamic nanoassembly-based drug delivery systems on the horizon. J Control Release 2021;339:547-52. [PMID: 34478749 DOI: 10.1016/j.jconrel.2021.08.045] [Reference Citation Analysis]
8 Rodríguez-Izquierdo I, Sepúlveda-Crespo D, Lasso JM, Resino S, Muñoz-Fernández MÁ. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1774. [PMID: 35018739 DOI: 10.1002/wnan.1774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mochizuki C, Nakamura J, Nakamura M. Development of Non-Porous Silica Nanoparticles towards Cancer Photo-Theranostics. Biomedicines 2021;9:73. [PMID: 33451074 DOI: 10.3390/biomedicines9010073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Pandey J, Dubey R, Kate A, Prasad B, Sinha A, Mishra MS. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement. Drug Res (Stuttg). [DOI: 10.1055/a-1824-4619] [Reference Citation Analysis]
11 Wang C, Liu Y, Chen R, Wang X, Wang Y, Wei J, Zhang K, Zhang C. Electrochemical biosensing of circulating microRNA-21 in cerebrospinal fluid of medulloblastoma patients through target-induced redox signal amplification. Microchim Acta 2022;189. [DOI: 10.1007/s00604-022-05210-y] [Reference Citation Analysis]
12 Xu K, Jiang X, Ariston Gabriel AN, Li X, Wang Y, Xu S. Evolving Landscape of Long Non-coding RNAs in Cerebrospinal Fluid: A Key Role From Diagnosis to Therapy in Brain Tumors. Front Cell Dev Biol 2021;9:737670. [PMID: 34692695 DOI: 10.3389/fcell.2021.737670] [Reference Citation Analysis]
13 Luiz MT, Delello Di Filippo L, Tofani LB, de Araújo JTC, Dutra JAP, Marchetti JM, Chorilli M. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. Int J Pharm 2021;604:120758. [PMID: 34090991 DOI: 10.1016/j.ijpharm.2021.120758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Perrelli A, Fatehbasharzad P, Benedetti V, Ferraris C, Fontanella M, De Luca E, Moglianetti M, Battaglia L, Retta SF. Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM). Expert Opin Drug Deliv 2021;18:849-76. [PMID: 33406376 DOI: 10.1080/17425247.2021.1873273] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang L, Sun H, Zhao J, Lee J, Ee Low L, Gong L, Chen Y, Wang N, Zhu C, Lin P, Liang Z, Wei M, Ling D, Li F. Dynamic nanoassemblies for imaging and therapy of neurological disorders. Adv Drug Deliv Rev 2021;175:113832. [PMID: 34146626 DOI: 10.1016/j.addr.2021.113832] [Reference Citation Analysis]